Board of Scientific Counselors, National Center for Public Health Informatics (BSC, NCPHI), 41712 [E9-19754]
Download as PDF
41712
Federal Register / Vol. 74, No. 158 / Tuesday, August 18, 2009 / Notices
jlentini on DSKJ8SOYB1PROD with NOTICES
ACTION: Notice; reopening of comment
period.
SUMMARY: The Food and Drug
Administration (FDA) is reopening until
November 6, 2009, the comment period
for the notice of public meeting and
request for comments that appeared in
the Federal Register of June 3, 2009 (74
FR 26712). In the notice of public
meeting and request for comments,
FDA’s Transparency Task Force
requested comments on ways in which
FDA can make useful and
understandable information about FDA
activities and decision making more
readily available to the public. The
agency is taking this action because the
agency is planning a second public
meeting this fall and is reopening the
comment period to allow interested
persons additional time to submit
comments.
DATES: Submit written or electronic
comments by November 6, 2009.
ADDRESSES: Submit written comments
to the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.regulations.gov. All such
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT: Afia
Asamoah, Office of the Commissioner,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 1, rm. 2208,
Silver Spring, MD 20993, 301–796–
4625, FAX: 301–847–3531, e-mail:
Afia.Asamoah@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the
Federal Register of June 3, 2009 (74 FR
26712), FDA published a notice of
public meeting and request for
comments on ways in which FDA can
make useful and understandable
information about FDA activities and
decisionmaking more readily available
to the public, in a manner compatible
with the agency’s goal of protecting
confidential information, as appropriate.
Interested persons were given until
August 7, 2009, to submit comments.
The agency is planning to hold a second
meeting in the fall of 2009 about these
issues and is reopening the comment
period until November 6, 2009. FDA has
also established an online blog at https://
fdatransparencyblog.fda.gov in which
interested persons may provide
feedback on specific topics. The blog is
expected to run through November
2009.
Interested persons may submit written
or electronic comments to the Division
of Dockets Management (see
VerDate Nov<24>2008
16:30 Aug 17, 2009
Jkt 217001
ADDRESSES).
Submit a single copy of
electronic comments to https://
www.reguations.gov or two paper copies
of any mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Dated: August 12, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–19778 Filed 8–17–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Public Health
Informatics (BSC, NCPHI)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 8:30 a.m.–5 p.m.,
September 2, 2009.
Place: Hyatt Regency, 265 Peachtree
Street NE., Atlanta, Georgia, 30303 Tel:
(404) 577–1234, Fax: (404) 588–4137.
Maps & Directions
This meeting will also be
teleconferenced: Toll Free Number:
(866) 713–5586, Participant’s pass code
4624038.
Status: Open to the public, limited
only by the space available.
Purpose: The committee shall advise
the Secretary, HHS, and the Director,
CDC, concerning strategies and goals for
the programs and research within the
national centers; shall conduct peerreview of scientific programs; and
monitor the overall strategic direction
and focus of the national centers. The
board, after conducting its periodic
reviews, shall submit a written
description of the results of the review
and its recommendations to the
Director, CDC. The board shall perform
second-level peer review of applications
for grants-in-aid for research and
research training activities, cooperative
agreements, and research contract
proposals relating to the broad areas
within the national center.
Matters to be Discussed: The board
will discuss BSC, NCPHI-related
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
matters, including an update on NCPHI
Programs and other BSC-related
activities.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Dr. Scott McNabb, National Center for
Public Health Informatics, CDC, 1600
Clifton Road, NE., Mailstop E–78,
Atlanta, Georgia 30333, Telephone (404)
498–6427, Fax (404) 498–6235.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the CDC
and the Agency for Toxic Substance and
Disease Registry.
Dated: August 10, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–19754 Filed 8–17–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory General Medical
Sciences Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
General Medical Sciences Council.
Date: September 10–11, 2009.
Closed: September 10, 2009, 8:30 a.m. to 5
p.m.
E:\FR\FM\18AUN1.SGM
18AUN1
Agencies
[Federal Register Volume 74, Number 158 (Tuesday, August 18, 2009)]
[Notices]
[Page 41712]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-19754]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Public Health
Informatics (BSC, NCPHI)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 8:30 a.m.-5 p.m., September 2, 2009.
Place: Hyatt Regency, 265 Peachtree Street NE., Atlanta, Georgia,
30303 Tel: (404) 577-1234, Fax: (404) 588-4137.
Maps & Directions
This meeting will also be teleconferenced: Toll Free Number: (866)
713-5586, Participant's pass code 4624038.
Status: Open to the public, limited only by the space available.
Purpose: The committee shall advise the Secretary, HHS, and the
Director, CDC, concerning strategies and goals for the programs and
research within the national centers; shall conduct peer-review of
scientific programs; and monitor the overall strategic direction and
focus of the national centers. The board, after conducting its periodic
reviews, shall submit a written description of the results of the
review and its recommendations to the Director, CDC. The board shall
perform second-level peer review of applications for grants-in-aid for
research and research training activities, cooperative agreements, and
research contract proposals relating to the broad areas within the
national center.
Matters to be Discussed: The board will discuss BSC, NCPHI-related
matters, including an update on NCPHI Programs and other BSC-related
activities.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Dr. Scott McNabb, National
Center for Public Health Informatics, CDC, 1600 Clifton Road, NE.,
Mailstop E-78, Atlanta, Georgia 30333, Telephone (404) 498-6427, Fax
(404) 498-6235.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the CDC and the Agency for Toxic Substance and Disease Registry.
Dated: August 10, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-19754 Filed 8-17-09; 8:45 am]
BILLING CODE 4163-18-P